MICHELLE HARBAN: Open Payments
NPI 1770033995 · OSKALOOSA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 11 payments from 8 companies in 2025. Trend: 2023 $164 · 2024 $756 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $150 |
| SERVIER PHARMACEUTICALS LLC | 1 | $91 |
| Myriad Genetic Laboratories, Inc. | 2 | $44 |
| Eisai Inc. | 2 | $40 |
| Astellas Pharma US Inc | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: ELAHERE, MYRISK, Lenvima, Veozah, KEYTRUDA, JEMPERLI, LYNPARZA.
Industry payments across IA — which companies pay providers there.
